Evidence map›Paper›PMID 37129645›Full record

ReviewDiscover oncology2023

ANXA6: a key molecular player in cancer progression and drug resistance.

Jinlong Cao, Shun Wan, Siyu Chen, Li Yang

Open access · goldAbstract readReview
In one paragraph

Review in Discover oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Annexin, a Protein for All Seasons: From Calcium Dependent Membrane Metabolism to RNA Recognition.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  7. Article
  8. EnterohemorrhagicAIMS microbiology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Co-expression of the Mammaglobin (Cancer diagnosis & prognosis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jinlong Cao *Department of Urology, Lanzhou University Second Hospital, Lanzhou, 730000, China.
Shun Wan *Department of Urology, Lanzhou University Second Hospital, Lanzhou, 730000, China.
Siyu Chen *Department of Urology, Lanzhou University Second Hospital, Lanzhou, 730000, China.
Li YangDepartment of Urology, Lanzhou University Second Hospital, Lanzhou, 730000, China. ery_yangli@lzu.edu.cn.
Lanzhou University Second Hospital · CNLanzhou University · CNMinzu University of China · CN

Funding

Gansu Province Intellectual Property Planning project 21ZSCQ012the Gansu Provincial Education Department outstanding graduate "innovation star" project 2021CXZX-154the Second Hospital of Lanzhou University "Cuiying Science and Technology Innovation" project CY2021-QN-A20
6 · The paper itself

Abstract

Annexin-A6 (ANXA6), a Ca

Indexed as

ANXA6Drug resistanceMembrane repairMetabolic reprogrammingMigration

Identifiers

PMID37129645
PMCPMC10154440
OpenAlexW4367669289

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.